Cargando…
Short Stature in Chronic Kidney Disease Treated with Growth Hormone and an Aromatase Inhibitor
We describe an alternative strategy for management of severe growth failure in a 14-year-old child who presented with advanced chronic kidney disease close to puberty. The patient was initially treated with growth hormone for a year until kidney transplantation, followed immediately by a year-long c...
Autores principales: | Mendley, Susan R., Spyropoulos, Fotios, Counts, Debra R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458562/ https://www.ncbi.nlm.nih.gov/pubmed/26101681 http://dx.doi.org/10.1155/2015/738571 |
Ejemplares similares
-
Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program
por: Miller, Bradley S., et al.
Publicado: (2020) -
The use of aromatase inhibitors in boys with short stature: what to know before prescribing?
por: Linardi, Alessandra, et al.
Publicado: (2017) -
The Northern Ireland experience of growth hormone therapy for short stature.
por: Whitehead, H. M., et al.
Publicado: (1989) -
Prevalence of Short Stature and Growth Hormone Deficiency and Factors Associated With Short Stature After Fontan Surgery
por: Matsumura, Shun, et al.
Publicado: (2020) -
Evaluation of craniofacial morphology in short-statured children: growth hormone deficiency versus idiopathic short stature
por: Kim, Ki Bong, et al.
Publicado: (2020)